Ed Kong
@edkong
MD/PhD student in economics @HarvardEcon, @harvardMed, and @HarvardMITmdphd. Originally @Yale BME/Econ. Researching health care markets.
Demand curves sloping down once again undefeated
it's hilarious how high the elasticity is here, my goodness
Truly an honor to have had the chance to write this paper with @AMostaghimi
Specialty medications, particularly new biologics, contributed to the rise in dermatology drug spending under #Medicare Part D from 2013 to 2022, primarily due to increased prescribing. ja.ma/3GKTImi @edkong
Not too much goin' on today, so I thought I'd tell you about a new paper just published in @NEJMEvidence, w/ @metrics52, @carolxmgao, and @rwyeh We explain why instrumental variable (IV) methods are essential for randomized trials of medical interventions that fail to play out…
The best study I know estimates that each dollar of NIH spending generates $1.40-$2.80 in value counting *only the private return from drugs*, ignoring consumer surplus, med devices, public health, behavioral science, etc...
Every synthetic biologist, every biochemist, when they dream, will sometimes hear a voice calling A whisper on the wind, as impossible as infinity, as sweet as the ambrosia of the very Gods "Engineer RuBisCo" And this paper takes us one step closer nature.com/articles/s4158…
BREAKING: California Insurance Commissioner @RicardoLara4CA has issued a mandatory one-year moratorium that will prohibit insurance companies from enacting non-renewals and cancellations of coverage for home owners within the perimeters or adjoining ZIP Codes of the Palisades and…
BREAKING: California Insurance Commissioner @RicardoLara4CA has issued a mandatory one-year moratorium that will prohibit insurance companies from enacting non-renewals and cancellations of coverage for home owners within the perimeters or adjoining ZIP Codes of the Palisades and…
